Cargando…
The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer
Immunotherapies targeting truly tumor-specific targets focus on the expansion and activation of T cells against neoantigens or oncogenic viruses. One target is the human papilloma virus type 16 (HPV16), responsible for several anogenital cancers and oropharyngeal carcinomas. Spontaneous and vaccine-...
Autores principales: | Santegoets, Saskia J., Welters, Marij J. P., Schrikkema, Deborah S., Freriks, Manon R., Kok, Hanna, Weissbrich, Bianca, van den Branden, Anouk, Linnemann, Carsten, Schumacher, Ton N., Adhikary, Sabina, Bendle, Gavin, van der Burg, Sjoerd H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198845/ https://www.ncbi.nlm.nih.gov/pubmed/36526910 http://dx.doi.org/10.1007/s00262-022-03350-x |
Ejemplares similares
-
The combined HPV16-E2/E6/E7 T cell response in oropharyngeal cancer predicts superior survival
por: Santegoets, Saskia J., et al.
Publicado: (2023) -
Detection and functional assessment of regulatory T cells in clinical samples
por: Santegoets, Saskia, et al.
Publicado: (2014) -
The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma
por: Welters, Marij J. P., et al.
Publicado: (2020) -
Monitoring of the Immune Dysfunction in Cancer Patients
por: Santegoets, Saskia J. A. M., et al.
Publicado: (2016) -
Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies
por: Tubb, Vanessa M., et al.
Publicado: (2018)